Clinical Trial Update: Omission of ALND in Breast Cancer Patients With Axillary pCR [NA]

View source ↗

Summary

A clinical trial update indicating recruitment for omitting axillary lymph node dissection in breast cancer patients with axillary pathological complete respons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Axillary Lymph Node Dissection, Pathological Complete Response | NA | Status: RECRUITING